Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-20-048175

Chief Medical Officer gave up 1,954 shares (to pay taxes)

  • Chief Medical Officer acquired 5,643 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2020-08-20 Option exercise +5,643 8,465 D
Ho Carole Chief Medical Officer 2020-08-21 Shares withheld for taxes −1,954 $32.88 $64,248 6,511 D
Derivatives
Ho Carole Chief Medical Officer 2020-08-20 Option exercise · Restricted Stock Units −5,643 0 D
Loading xslF345X03/doc4.xml…